When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
It is already known that heart problems and diseases are caused by excess bad fat.High levels of triglycerides, a type of fat ...
Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, remnant cholesterol and fat in models and a Phase 1 trial without harming ...
A study led by researchers from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, revealed a new liver- and ...
Madrid, Spain – 30 August 2025: Olezarsen decreased levels of triglycerides compared with placebo in patients with moderate hypertriglyceridaemia and elevated cardiovascular risk, according to a ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...